Clinical Trials Logo

Advanced Stage clinical trials

View clinical trials related to Advanced Stage.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03628521 Recruiting - Lung Cancer Clinical Trials

First-line Combination Treatment Based on Anlotinib

Start date: July 20, 2018
Phase: Phase 1
Study type: Interventional

The aim of this study is to explore safety and therapeutic efficacy of anlotinib combined with erlotinib/chemotherapy/IBI308 as first-line treatment in advanced NSCLC patients. The primary endpoints of the study are safety and objective response rate (ORR);the secondary endpoints are disease control rate (DCR), progression-free survival (PFS) and overall survival (OS).